Cosmo Pharmaceuticals S.p.A Stock Swiss Exchange
Stocks
IT0004167463
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Swiss Exchange
|
||
| - CHF | - |
|
| 08-28 | Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation | RE |
| 08-14 | Cosmo Pharmaceuticals to Adopt New Ticker on SIX Swiss Exchange | MT |
| Market Cap | 1.07B 1.21B 1B 916M 1.71B 116B 1.72B 12.04B 4.67B 59.33B 4.56B 4.46B 192B | P/E 2026 * |
922x | P/E 2027 * | 21.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.04B 1.18B 975M 892M 1.67B 113B 1.68B 11.72B 4.54B 57.74B 4.44B 4.34B 187B | EV / Sales 2026 * |
9.76x | EV / Sales 2027 * | 5.89x |
| Free-Float |
40.52% | Yield 2026 * |
3.43% | Yield 2027 * | 3.64% |
Last Transcript: Cosmo Pharmaceuticals S.p.A
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 2024-05-23 | |
| Director of Finance/CFO | - | 2024-11-10 | |
Paolo Lanzarotti
CTO | Chief Tech/Sci/R&D Officer | 53 | 2008-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mauro Ajani
CHM | Chairman | 71 | 2013-12-31 |
| Director/Board Member | 71 | 2012-03-31 | |
Niall Donnelly
BRD | Director/Board Member | 54 | 2024-05-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.64% | +1.16% | +54.09% | +109.07% | 1,043B | |
| -0.01% | +0.71% | +52.44% | +67.71% | 649B | |
| -0.05% | +0.98% | +19.08% | +73.55% | 469B | |
| -0.25% | +0.19% | +36.95% | +45.63% | 355B | |
| +0.98% | +2.91% | +20.59% | +27.91% | 270B | |
| -1.91% | +2.42% | +10.41% | +12.53% | 262B | |
| -1.01% | +7.90% | +41.59% | +51.70% | 222B | |
| -0.85% | +2.50% | +32.32% | +101.80% | 189B | |
| -2.53% | -7.47% | -32.63% | -60.67% | 175B | |
| Average | -0.24% | +1.42% | +26.09% | +47.69% | 403.67B | |
| Weighted average by Cap. | +0.44% | +1.34% | +35.89% | +65.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 106M 121M 99.92M 91.35M 171M 11.6B 172M 1.2B 465M 5.91B 455M 445M 19.18B | 176M 201M 165M 151M 283M 19.21B 285M 1.99B 770M 9.79B 753M 737M 31.75B |
| Net income | 1.27M 1.45M 1.2M 1.1M 2.05M 139M 2.06M 14.39M 5.58M 70.92M 5.45M 5.33M 230M | 49.6M 56.51M 46.63M 42.63M 79.66M 5.41B 80.25M 560M 217M 2.76B 212M 208M 8.95B |
| Net Debt | -28.5M -32.47M -26.79M -24.49M -45.77M -3.11B -46.11M -322M -125M -1.59B -122M -119M -5.14B | -28.81M -32.82M -27.08M -24.76M -46.26M -3.14B -46.6M -325M -126M -1.6B -123M -121M -5.2B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
